Cigna Corp
NYSE:CI
Relative Value
The Relative Value of one CI stock under the Base Case scenario is 726.51 USD. Compared to the current market price of 357.99 USD, Cigna Corp is Undervalued by 51%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
CI Competitors Multiples
Cigna Corp Competitors
Market Cap | P/S | P/E | P/B | ||||
---|---|---|---|---|---|---|---|
US |
Cigna Corp
NYSE:CI
|
104.7B USD | 0.5 | 20.3 | 2.3 | ||
US |
C
|
Cigna Group
XMUN:CGN
|
96.6B EUR | 0.5 | 20 | 2.2 | |
US |
CVS Health Corp
NYSE:CVS
|
87.1B USD | 0.2 | 10.4 | 1.1 | ||
DE |
Fresenius Medical Care AG
XMUN:FME
|
22B EUR | 1.1 | 44.1 | 1.6 | ||
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
17.5B USD | 1.4 | 40.3 | 2.2 | ||
DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.6B EUR | 0.7 | -26.3 | 0.8 | |
US |
Quest Diagnostics Inc
NYSE:DGX
|
15.7B USD | 1.7 | 18.7 | 2.4 | ||
US |
DaVita Inc
NYSE:DVA
|
12.2B USD | 1 | 17.6 | 11.5 | ||
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.4B EUR | 0.6 | 22.8 | 0.8 | |
US |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 4.4 | -18.6 | -34.9 | ||
US |
Chemed Corp
NYSE:CHE
|
8.5B USD | 3.7 | 29.9 | 7.2 |